Insight Molecular Diagnostics Inc. (IMDX)

NASDAQ: IMDX · Real-Time Price · USD

6.64

+0.01 (0.23%)

At close: Jan 16, 2026, 4:00 PM EST

6.77

+0.13 (2.03%)

After-hours: Jan 16, 2026, 5:37 PM EST

IMDX Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jan '26 Jan 16, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	190	40	21	38	200	161	Upgrade
Market Cap Growth	374.29%	94.02%	-45.76%	-80.98%	24.52%	25.25%	Upgrade
Enterprise Value	175	41	14	14	162	159	Upgrade
Last Close Price	6.63	2.38	2.50	6.42	43.40	47.80	Upgrade
PS Ratio	40.41	21.30	13.74	39.74	91.06	132.18	Upgrade
PB Ratio	-	-3.26	0.81	0.96	3.07	4.80	Upgrade
P/TBV Ratio	-	-	-	-	-	17.31	Upgrade
EV/Sales Ratio	39.67	21.64	9.60	15.07	73.75	130.37	Upgrade
Debt / Equity Ratio	-0.34	-0.30	0.11	0.09	0.09	0.26	Upgrade
Debt / EBITDA Ratio	0.01	0.01	0.00	-	-	-	Upgrade
Asset Turnover	0.08	0.03	0.02	0.01	0.02	0.03	Upgrade
Quick Ratio	2.47	1.41	1.38	1.85	2.50	0.89	Upgrade
Current Ratio	2.79	1.62	1.49	2.11	2.77	1.03	Upgrade
Return on Equity (ROE)	-23603.11%	-910.86%	-76.26%	-35.52%	-88.37%	-93.07%	Upgrade
Return on Assets (ROA)	-28.44%	-26.42%	-15.91%	-13.88%	-13.82%	-42.66%	Upgrade
Return on Invested Capital (ROIC)	-425.26%	-146.37%	-38.88%	-31.60%	-26.30%	-51.52%	Upgrade
Return on Capital Employed (ROCE)	-71.60%	-83.60%	-32.90%	-32.80%	-16.30%	-70.00%	Upgrade
Earnings Yield	-31.96%	-151.40%	-134.52%	-191.48%	-32.03%	-18.62%	Upgrade
FCF Yield	-12.58%	-52.98%	-114.30%	-131.09%	-19.08%	-16.93%	Upgrade
Buyback Yield / Dilution	-148.58%	-70.84%	-38.10%	-24.61%	-35.80%	-27.65%	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q